There are no approved vaccines or treatments for Sudan virus disease, which has a 40–70% fatality rate. To curb the ongoing outbreak, Uganda has deployed—under a clinical trial setting—a vaccine ...
WHO and the Uganda Health Ministry have launched a first-ever vaccine trial for the species of Ebola at the center of an ongoing outbreak in Uganda’s capital city.
A laboratory holding Ebola and other dangerous pathogens in the eastern DR Congo city of Goma—which has been seized by the ...
Ebola is rare, deadly and has multiple variants. There is a vaccine for the Zaire type. Now, trials for another strain are ...
The Cool Down on MSN1d
Scientists make major breakthrough that may curb the threat of Ebola: 'Information we should have'"If we don't know what the wildlife host is, we can't know how, where or when that will be." Scientists make major ...
Cryo-EM structure of Sudan ebolavirus glycoprotein complexed with its human endosomal receptor NPC1 - (https://www.nature.com ...
The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it infects cells. Currently, no approved treatments exist. To address this critical ...
A new study finds that the Sudan virus, a deadly Ebola relative, binds to human NPC1 receptors with nine times greater ...
Sudan virus (SUDV) can infect people to cause Sudan virus disease (SVD). Right now, an outbreak of SVD has been detected in ...
A fatal virus has been discovered in shrews in Alabama, sparking concerns about potential contagion to humans. The Camp Hill ...
The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it ...
The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it infects cells. Currently, no approved treatments exist.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback